PRISM: A Platform Protocol for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
Year: 2019
Type: conference-abstract
Source: Blood
Authors: Mark Roschewski, Raquel Izumi, Ahmed Hamdy, Manish R. Patel, Hendrik-Tobias Arkenau, Sven de Vos, Patrick M Reagan, Pier Luigi Zinzani, Andrew Davies, John M Pagel, Julie M Vose, Bojena Bitman, Graham Brock, Edwin Clark, Melanie M. Frigault, Joseph Ware, Buyue Yang, Wyndham Wilson, Louis Staudt, Ian W. Flinn
Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Acerta Pharma BV (Netherlands), Sarah Cannon Research Institute, University College London, University of California, Los Angeles, University of Rochester Medicine, University of Rochester, Istituto di Ematologia di Bologna, University of Bologna, Cancer Research UK, University of Southampton, University of Nebraska Medical Center, AstraZeneca (United States), Sarah Cannon
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2985357706